Cover Image
市場調查報告書

糖尿病性高血壓:全球臨床實驗檢討

Diabetic Hypertension Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 312388
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
Back to Top
糖尿病性高血壓:全球臨床實驗檢討 Diabetic Hypertension Global Clinical Trials Review, H2, 2014
出版日期: 2014年08月30日 內容資訊: 英文 62 Pages
簡介

本報告提供糖尿病性高血壓相關臨床研究的最新趨勢分析,提供您疾病·治療方法概要,及G7各國的臨床實驗狀況,地區、階段、phase別進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 糖尿病性高血壓
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 主要國家的臨床實驗數量; 亞太地區
    • 主要國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: 糖尿病性高血壓 臨床實驗數量中心臟血管臨床實驗數量比率

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量: 糖尿病性高血壓 臨床實驗數量中心臟血管臨床實驗數量比率

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 糖尿病性高血壓 治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Troikaa Pharmaceuticals Ltd.
    • Sanofi
    • Novartis AG
  • 有代表性的研究機關醫院臨床實驗概要
    • 東京慈惠會醫科大學
    • 順天堂大學醫學系
    • 東京大學大學院醫學系研究科·醫學系
    • Hospital Universitario Pedro Ernesto
    • 琦玉醫科大學
    • 順天堂大學
    • 大阪大學
    • University of Pavia
    • University of Southern Denmark
    • Medical University of Vienna

5大臨床實驗簡介

圖表一覽

目錄

GlobalData's clinical trial report, "Diabetic Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Diabetic Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Diabetic Hypertension
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Diabetic Hypertension
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Diabetic Hypertension Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Troikaa Pharmaceuticals Ltd.
      • Clinical Trial Overview of Troikaa Pharmaceuticals Ltd.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
    • Clinical Trial Overview of Top Institutes / Government
      • Jikei University School of Medicine
      • Clinical Trial Overview of Jikei University School of Medicine
      • Juntendo University School of Medicine
      • Clinical Trial Overview of Juntendo University School of Medicine
      • Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
      • Clinical Trial Overview of Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
      • Hospital Universitario Pedro Ernesto
      • Clinical Trial Overview of Hospital Universitario Pedro Ernesto
      • Saitama Medical University
      • Clinical Trial Overview of Saitama Medical University
      • Juntendo University
      • Clinical Trial Overview of Juntendo University
      • Osaka University
      • Clinical Trial Overview of Osaka University
      • University of Pavia
      • Clinical Trial Overview of University of Pavia
      • University of Southern Denmark
      • Clinical Trial Overview of University of Southern Denmark
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Diabetic Hypertension Therapeutics, Global, Clinical Trials by Region, 2014*
  • Diabetic Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Diabetic Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Diabetic Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Diabetic Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Diabetic Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Diabetic Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Diabetic Hypertension Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Diabetic Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Diabetic Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Diabetic Hypertension Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Diabetic Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Troikaa Pharmaceuticals Ltd., 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Jikei University School of Medicine, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Pedro Ernesto, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pavia, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern Denmark, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*

List of Figures

  • Diabetic Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Diabetic Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Diabetic Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Diabetic Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Diabetic Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Diabetic Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Diabetic Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Diabetic Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Diabetic Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Diabetic Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Diabetic Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Diabetic Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top